Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey

Abstract Background Severe infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary i...

Full description

Bibliographic Details
Main Authors: Christian Lanckohr, Christian Boeing, Jan J. De Waele, Dylan W. de Lange, Jeroen Schouten, Menno Prins, Maarten Nijsten, Pedro Povoa, Andrew Conway Morris, Hendrik Bracht
Format: Article
Language:English
Published: SpringerOpen 2021-08-01
Series:Annals of Intensive Care
Subjects:
Online Access:https://doi.org/10.1186/s13613-021-00917-2
id doaj-6e5e130ed1ff40ae95451b39246bbef6
record_format Article
spelling doaj-6e5e130ed1ff40ae95451b39246bbef62021-08-29T11:04:06ZengSpringerOpenAnnals of Intensive Care2110-58202021-08-011111810.1186/s13613-021-00917-2Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU surveyChristian Lanckohr0Christian Boeing1Jan J. De Waele2Dylan W. de Lange3Jeroen Schouten4Menno Prins5Maarten Nijsten6Pedro Povoa7Andrew Conway Morris8Hendrik Bracht9Antibiotic Stewardship Team, Department of Hygiene, University Hospital MünsterAntibiotic Stewardship Team, Department of Hygiene, University Hospital MünsterDepartment of Critical Care Medicine, Ghent University HospitalDepartment of Intensive Care Medicine, Universitair Medisch Centrum, University UtrechtDepartment of Intensive Care, Radboud UMCDept. Biomedical Engineering, Eindhoven University of TechnologyDepartment of Intensive Care Medicine, University of GroningenPolyvalent Intensive Care Unit, Hospital de São Francisco XavierDivision of Anaesthesia, University of CambridgeClinic for Anesthesiology, University Hospital UlmAbstract Background Severe infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary insights into dissemination and structure of AMS programs and TDM practices in intensive care units. Methods This study involved online survey of members of ESICM and six national professional intensive care societies. Results Data of 812 respondents from mostly European high- and middle-income countries were available for analysis. 63% had AMS rounds available in their ICU, where 78% performed rounds weekly or more often. While 82% had local guidelines for treatment of infections, only 70% had cumulative antimicrobial susceptibility reports and 56% monitored the quantity of antimicrobials administered. A restriction of antimicrobials was reported by 62%. TDM of antimicrobial agents was used in 61% of ICUs, mostly glycopeptides (89%), aminoglycosides (77%), carbapenems (32%), penicillins (30%), azole antifungals (27%), cephalosporins (17%), and linezolid (16%). 76% of respondents used prolonged/continuous infusion of antimicrobials. The availability of an AMS had a significant association with the use of TDM. Conclusions Many respondents of the survey have AMS in their ICUs. TDM of antimicrobials and optimized administration of antibiotics are broadly used among respondents. The availability of antimicrobial susceptibility reports and a surveillance of antimicrobial use should be actively sought by intensivists where unavailable. Results of this survey may inform further research and educational activities.https://doi.org/10.1186/s13613-021-00917-2Antimicrobial stewardshipTherapeutic drug monitoringCritical careMultiresistant bacteriaAntibiotic
collection DOAJ
language English
format Article
sources DOAJ
author Christian Lanckohr
Christian Boeing
Jan J. De Waele
Dylan W. de Lange
Jeroen Schouten
Menno Prins
Maarten Nijsten
Pedro Povoa
Andrew Conway Morris
Hendrik Bracht
spellingShingle Christian Lanckohr
Christian Boeing
Jan J. De Waele
Dylan W. de Lange
Jeroen Schouten
Menno Prins
Maarten Nijsten
Pedro Povoa
Andrew Conway Morris
Hendrik Bracht
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
Annals of Intensive Care
Antimicrobial stewardship
Therapeutic drug monitoring
Critical care
Multiresistant bacteria
Antibiotic
author_facet Christian Lanckohr
Christian Boeing
Jan J. De Waele
Dylan W. de Lange
Jeroen Schouten
Menno Prins
Maarten Nijsten
Pedro Povoa
Andrew Conway Morris
Hendrik Bracht
author_sort Christian Lanckohr
title Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
title_short Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
title_full Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
title_fullStr Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
title_full_unstemmed Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
title_sort antimicrobial stewardship, therapeutic drug monitoring and infection management in the icu: results from the international a- teamicu survey
publisher SpringerOpen
series Annals of Intensive Care
issn 2110-5820
publishDate 2021-08-01
description Abstract Background Severe infections and multidrug-resistant pathogens are common in critically ill patients. Antimicrobial stewardship (AMS) and therapeutic drug monitoring (TDM) are contemporary tools to optimize the use of antimicrobials. The A-TEAMICU survey was initiated to gain contemporary insights into dissemination and structure of AMS programs and TDM practices in intensive care units. Methods This study involved online survey of members of ESICM and six national professional intensive care societies. Results Data of 812 respondents from mostly European high- and middle-income countries were available for analysis. 63% had AMS rounds available in their ICU, where 78% performed rounds weekly or more often. While 82% had local guidelines for treatment of infections, only 70% had cumulative antimicrobial susceptibility reports and 56% monitored the quantity of antimicrobials administered. A restriction of antimicrobials was reported by 62%. TDM of antimicrobial agents was used in 61% of ICUs, mostly glycopeptides (89%), aminoglycosides (77%), carbapenems (32%), penicillins (30%), azole antifungals (27%), cephalosporins (17%), and linezolid (16%). 76% of respondents used prolonged/continuous infusion of antimicrobials. The availability of an AMS had a significant association with the use of TDM. Conclusions Many respondents of the survey have AMS in their ICUs. TDM of antimicrobials and optimized administration of antibiotics are broadly used among respondents. The availability of antimicrobial susceptibility reports and a surveillance of antimicrobial use should be actively sought by intensivists where unavailable. Results of this survey may inform further research and educational activities.
topic Antimicrobial stewardship
Therapeutic drug monitoring
Critical care
Multiresistant bacteria
Antibiotic
url https://doi.org/10.1186/s13613-021-00917-2
work_keys_str_mv AT christianlanckohr antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT christianboeing antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT janjdewaele antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT dylanwdelange antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT jeroenschouten antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT mennoprins antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT maartennijsten antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT pedropovoa antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT andrewconwaymorris antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
AT hendrikbracht antimicrobialstewardshiptherapeuticdrugmonitoringandinfectionmanagementintheicuresultsfromtheinternationalateamicusurvey
_version_ 1721187153027792896